Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1978-12-2
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0361-5960
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1375-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:688281-Adult,
pubmed-meshheading:688281-Aged,
pubmed-meshheading:688281-Carcinoma,
pubmed-meshheading:688281-Doxorubicin,
pubmed-meshheading:688281-Drug Evaluation,
pubmed-meshheading:688281-Female,
pubmed-meshheading:688281-Humans,
pubmed-meshheading:688281-Middle Aged,
pubmed-meshheading:688281-Neoplasm Recurrence, Local,
pubmed-meshheading:688281-Ovarian Neoplasms
|
pubmed:year |
1978
|
pubmed:articleTitle |
Adriamycin therapy for advanced ovarian carcinoma recurrent after chemotherapy.
|
pubmed:publicationType |
Journal Article
|